Found: 35
Select item for more details and to access through your institution.
Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma.
- Published in:
- Journal of Extracellular Vesicles, 2018, v. 7, n. 1, p. 1, doi. 10.1080/20013078.2018.1505403
- By:
- Publication type:
- Article
Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma.
- Published in:
- Journal of Extracellular Vesicles, 2018, v. 7, n. 1, p. 1, doi. 10.1080/20013078.2018.1505403
- By:
- Publication type:
- Article
FYN is overexpressed in human prostate cancer.
- Published in:
- BJU International, 2009, v. 103, n. 2, p. 171, doi. 10.1111/j.1464-410X.2008.08009.x
- By:
- Publication type:
- Article
Covalent Chemistry‐Mediated Multimarker Purification of Circulating Tumor Cells Enables Noninvasive Detection of Molecular Signatures of Hepatocellular Carcinoma.
- Published in:
- Advanced Materials Technologies, 2021, v. 6, n. 5, p. 1, doi. 10.1002/admt.202001056
- By:
- Publication type:
- Article
Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28340-6
- By:
- Publication type:
- Article
Detection of Live Circulating Tumor Cells by a Class of Near-Infrared Heptamethine Carbocyanine Dyes in Patients with Localized and Metastatic Prostate Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088967
- By:
- Publication type:
- Article
Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 3, p. 119, doi. 10.46883/onc.2021.3503.0119
- By:
- Publication type:
- Article
Third-Line Treatment Options for Kidney Cancer.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 9, p. 813
- By:
- Publication type:
- Article
Systemic Therapy in Renal Cell Carcinoma: Advancing Paradigms.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 3, p. 290
- By:
- Publication type:
- Article
Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03676-8
- By:
- Publication type:
- Article
Intensification of Androgen Deprivation Therapy in High-Risk, Nonmetastatic Prostate Cancer: Lessons From STAMPEDE.
- Published in:
- JNCI Cancer Spectrum, 2022, v. 6, n. 4, p. 1, doi. 10.1093/jncics/pkac044
- By:
- Publication type:
- Article
Frontiers in prostate cancer. Telomeres and chaos.
- Published in:
- Cancer (0008543X), 1995, v. 75, n. S7, p. 2027, doi. 10.1002/1097-0142(19950401)75:7+<2027::AID-CNCR2820751645>3.0.CO;2-6
- By:
- Publication type:
- Article
A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10878-3
- By:
- Publication type:
- Article
High-Purity Prostate Circulating Tumor Cell Isolation by a Polymer Nanofiber-Embedded Microchip for Whole Exome Sequencing.
- Published in:
- Advanced Materials, 2013, v. 25, n. 21, p. 2897, doi. 10.1002/adma.201205237
- By:
- Publication type:
- Article
Tumor Cell Isolation: High-Purity Prostate Circulating Tumor Cell Isolation by a Polymer Nanofiber-Embedded Microchip for Whole Exome Sequencing (Adv. Mater. 21/2013).
- Published in:
- Advanced Materials, 2013, v. 25, n. 21, p. 2870, doi. 10.1002/adma.201370136
- By:
- Publication type:
- Article
Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 9, p. 4639, doi. 10.1002/cam4.1695
- By:
- Publication type:
- Article
A prospective analysis of imatinib-induced c-kit modulation in ovarian cancer: A phase II clinical study with proteomic profiling.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 2, p. 309, doi. 10.1002/cncr.22757
- By:
- Publication type:
- Article
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer.
- Published in:
- 2007
- By:
- Publication type:
- journal article
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancerThis is a US government work and, as such, is in the public domain in the United States of America.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 7, p. 1323, doi. 10.1002/cncr.22545
- By:
- Publication type:
- Article
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming.
- Published in:
- 2018
- By:
- Publication type:
- journal article
RNA Biomarkers: Glycan Stimulation Enables Purification of Prostate Cancer Circulating Tumor Cells on PEDOT NanoVelcro Chips for RNA Biomarker Detection (Adv. Healthcare Mater. 3/2018).
- Published in:
- Advanced Healthcare Materials, 2018, v. 7, n. 3, p. 1, doi. 10.1002/adhm.201870013
- By:
- Publication type:
- Article
Glycan Stimulation Enables Purification of Prostate Cancer Circulating Tumor Cells on PEDOT NanoVelcro Chips for RNA Biomarker Detection.
- Published in:
- Advanced Healthcare Materials, 2018, v. 7, n. 3, p. 1, doi. 10.1002/adhm.201700701
- By:
- Publication type:
- Article
Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study.
- Published in:
- Prostate, 2016, v. 76, n. 3, p. 286, doi. 10.1002/pros.23119
- By:
- Publication type:
- Article
Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE).
- Published in:
- 2021
- By:
- Publication type:
- journal article
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer.
- Published in:
- Nucleic Acids Research, 2024, v. 52, n. 13, p. 7740, doi. 10.1093/nar/gkae547
- By:
- Publication type:
- Article
Circulating Tumor Cells in Prostate Cancer: Beyond Enumeration.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. 1, p. 63
- By:
- Publication type:
- Article
Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 18, p. 3240, doi. 10.1002/cncr.29455
- By:
- Publication type:
- Article
Fyn: a novel molecular target in cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
A Novel Molecular Target in Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 7, p. 1629, doi. 10.1002/cncr.24879
- By:
- Publication type:
- Article
Disparities in Cancer Care and the Asian American Population.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. 453, doi. 10.1002/onco.13748
- By:
- Publication type:
- Article
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti‐Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 2, p. 202, doi. 10.1634/theoncologist.2018-0299
- By:
- Publication type:
- Article
Circulating Fatty Objects and Their Preferential Presence in Pancreatic Cancer Patient Blood Samples.
- Published in:
- Frontiers in Physiology, 2022, v. 13, p. 1, doi. 10.3389/fphys.2022.827531
- By:
- Publication type:
- Article
A practical guide for assessing and managing cardiovascular risk during androgen‐deprivation therapy in patients with prostate cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 11, p. 1916, doi. 10.1002/cncr.35285
- By:
- Publication type:
- Article
Loss of testosterone impairs anti-tumor neutrophil function.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15397-4
- By:
- Publication type:
- Article